Stockscreener 앱 받기
6.11
7.14%
-0.47
시간 외 거래:
6.18
0.07
+1.15%
전일 마감가:
$6.58
열려 있는:
$6.59
하루 거래량:
366.46K
Relative Volume:
4.76
시가총액:
$72.98M
수익:
$59.14M
순이익/손실:
$-51.52M
주가수익비율:
-1.3928
EPS:
-4.387
순현금흐름:
$-11.88M
1주 성능:
-47.67%
1개월 성능:
-46.31%
6개월 성능:
-50.65%
1년 성능:
-63.78%
1일 변동 폭
$5.92
$6.70
1주일 범위
$5.92
$11.70
52주 변동 폭
$5.92
$16.94
Lensar Inc Stock (LNSR) Company Profile
명칭
Lensar Inc
전화
888-536-7271
주소
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
6.11 | 78.60M | 59.14M | -51.52M | -11.88M | -4.387 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-02-24 | 개시 | SVB Leerink | Outperform |
Lensar Inc 주식(LNSR)의 최신 뉴스
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
Lensar agrees to terminate sale to Alcon - MSN
LENSAR, Inc. Stock Plummets to New 52-Week Low of $6.70 - Markets Mojo
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR) - The Globe and Mail
Aug Gainers: Whats the MACD signal for LENSAR IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
This Block Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday - Benzinga
LNSR Stock Upgraded to Buy by BTIG Analyst Ryan Zimmerman | LNSR - GuruFocus
LNSR | LENSAR, Inc. Common Stock Analyst Forecasts - Quiver Quantitative
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
LENSAR cancels Alcon merger agreement, prepares strategic update - MSN
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com Canada
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
LENSAR Inc - Reuters
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
LENSAR stock plunges—Alcon scraps merger after prolonged regulatory review - MSN
Alcon abandons effort to purchase LENSAR after FTC scrutiny - MedTech Dive
LENSAR Terminates Merger Agreement with Alcon Following FTC Challenge, Retains $10M Deposit and Announces Strategic Update - Minichart
Lensar Share Slide on Terminated Merger Deal With Alcon - marketscreener.com
Alcon, LENSAR terminate merger agreement after US FTC opposition - MLex
Alcon, LENSAR Halt Merger Deal Amid FTC Scrutiny - Medical Product Outsourcing
BYND And LNSR Set The Tone Tuesday - TradingView
US FTC stops proposed merger of Alcon, LENSAR - MLex
US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon - TradingView
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Ends Alcon Merger, Plans Strategic Update - TipRanks
Lensar and Alcon Sign Termination Agreement; Lensar Retains $10 Million Deposit - TradingView
LENSAR (NASDAQ: LNSR) terminates Alcon merger, retains $10M and plans strategy update - Stock Titan
Alcon Inc stock terminates Lensar merger amid US regulatory hurdles, shifts focus to core growth - AD HOC NEWS
Lensar to terminate Alcon merger agreement - Yahoo Finance
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
Switzerland: Alcon and Lensar agree to terminate merger agreement - Investors in Healthcare
Switzerland's Alcon Abandons Lensar Deal as US Antitrust Hurdles Persist - marketscreener.com
Alcon terminates LENSAR acquisition after FTC opposition By Investing.com - Investing.com Australia
BTIG Upgrades LNSR (LENSAR, Inc.) to Buy on March 17, 2026 - Meyka
Lensar, Alcon terminate merger after FTC opposition By Investing.com - Investing.com Canada
Alcon, LENSAR agree to terminate merger agreement - MLex
Activity Recap: Can LENSAR Inc continue delivering strong returnsShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Alcon (ALC) and Lensar Call Off Merger Agreement - GuruFocus
Alcon (ALC) Ends Merger Talks with Lensar, Impacting Both Stocks - GuruFocus
Lensar (LNSR) and Alcon (ALC) Terminate Merger Agreement Amid FT - GuruFocus
Lensar, Alcon terminate merger after FTC opposition - Investing.com
Lensar announces termination of merger agreement with Alcon Research, LLC - marketscreener.com
Alcon terminates LENSAR acquisition after FTC opposition - Investing.com
Lensar and Alcon Agree to Terminate Merger - marketscreener.com
Alcon and Lensar agree to terminate merger agreement - marketscreener.com
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement - Business Wire
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC - GlobeNewswire
Lensar Inc (LNSR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):